Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/1999
05/28/1999CA2219271A1 1-deoxy-d-xylulose 5-phosphate synthase, a process for identifying effectors of 1-deoxy-d-xylulose 5-phosphate synthase and effectors of 1-deoxy-d-xylulose 5-phosphate synthase
05/27/1999WO1999025858A1 Alphavirus vectors for paramyxovirus vaccines
05/27/1999WO1999025836A1 Attaching substances to micro-organisms
05/27/1999WO1999025723A1 Chemical synthesis of 6-o-alkyl erythromycin a
05/27/1999WO1999025722A1 Process for n-desmethylating erythromycins and derivatives thereof
05/27/1999WO1999025718A1 5H-PYRANO[2,3-d:6,5-d']DIPYRIMIDINE DERIVATIVES HAVING AN ANTIBACTERIAL, ANTIVIRAL AND IMMUNO-MODULATING ACTIVITY
05/27/1999WO1999025714A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
05/27/1999WO1999025699A1 Salts of 5,5'-arylidenebisbarbituric and 5,5'-arylidenebis(2-thiobarbituric) acids and 5,5'-arylidenebis(2-thiobarbituric) acids having an antibacterial, anti-chlamydial, antiviral and immuno-modulating activity
05/27/1999WO1999025387A1 Recombinant vaccines comprising immunogenic attenuated bacteria having rpos positive phenotype
05/27/1999WO1999025379A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response
05/27/1999WO1999025378A1 Immunoglobulin molecules having a synthetic variable region and modified specificity
05/27/1999WO1999025377A1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection
05/27/1999WO1999025376A1 Bacterial vaccines comprising auxotrophic, attenuated strains of listeria expressing heterologous antigens
05/27/1999WO1999025352A1 Combination therapy for the treatment of aids
05/27/1999WO1999025343A1 Granules comprising clavulanate and one or more excipients
05/27/1999WO1999025341A1 Use of histamine for elevating blood histamine levels
05/27/1999WO1999014346A3 SENSE mRNA THERAPY
05/27/1999WO1999013092A9 Enhancement of mucosal antibody responses by interleukin-6
05/27/1999WO1999013084A9 Group a streptococcal vaccines
05/27/1999WO1999012563A3 Mucosal cytotoxic t lymphocyte responses
05/27/1999WO1999010371A3 Cyclopeptide derivatives as adhesion inhibitors
05/27/1999WO1999005270A3 Crustacean antimicrobial peptides, called penaiedines
05/27/1999DE19751948A1 Rapid preparation of 8-alkoxy-quinolone-carboxylic acid derivative antibacterial agent, e.g. gatifloxacin, in high purity
05/27/1999CA2628019A1 Chemical synthesis of 6-o-alkyl erythromycin a
05/27/1999CA2310410A1 Salts of 5,5'-arylidenebisbarbituric and 5,5'-arylidenebis(2-thiobarbituric) acids and 5,5'-arylidenebis(2-thiobarbituric) acids having an antibacterial, anti-chlamydial, antiviral and immuno-modulating activity
05/27/1999CA2310269A1 Immunoglobulin molecules having a synthetic variable region and modified specificity
05/27/1999CA2310255A1 Use of histamine for elevating blood histamine levels
05/27/1999CA2310228A1 Attaching substances to micro-organisms
05/27/1999CA2309990A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response
05/27/1999CA2309826A1 Alphavirus vectors for paramyxovirus vaccines
05/27/1999CA2309164A1 Combination therapy for the treatment of aids
05/27/1999CA2272402A1 Granules comprising clavulanate and one or more excipients
05/26/1999EP0917877A1 Remedies/preventives for viral infections, process for preparing the same, and method for preventing/treating viral infections
05/26/1999EP0917591A1 23s rna nucleotide fragment of the clhamydia genus bacteria, uses as probe, primer, and in a reagent and a detection and a detection method
05/26/1999EP0917576A1 Anti-herpesviral agents and assays therefor
05/26/1999EP0917572A2 Secreted proteins and polynucleotides encoding them
05/26/1999EP0917471A2 Treatment and diagnosis of infections of gram positive cocci
05/26/1999EP0817769B1 Borneol esters, process for their preparation and their pharmaceutical use
05/26/1999EP0804459A4 Therapeutic compound - fatty acid conjugates
05/26/1999EP0752991B1 IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONES ANTAGONISTS OF AMPA AND NMDA RECEPTORS
05/26/1999EP0707482B1 Erythromycin derivatives
05/26/1999EP0678034B1 Inducing cytotoxic t lymphocyte responses
05/26/1999EP0639195B1 2-acyloxycephem derivatives as elastase inhibitors
05/26/1999CN1217752A Process for producing high-molecular-weight compounds of phenolic compounds etc. and use thereof
05/26/1999CN1217714A Substituted indazole derivatives and their use as inhibitors phosphodiesterase (PDE) type IV and production of tumor necrosis factor (TNF)
05/26/1999CN1217660A Method for retreatment of patients afflicted with Hepatitis C using consensus interferon
05/26/1999CN1217335A Method for preparing precursor medicine
05/26/1999CN1217212A Vaccine both for hepatitis A and measles and production method therefor
05/25/1999US5906935 Cells transformed or transfected with HCMV US2-US5, US10-US11 genes
05/25/1999US5906821 Viral nucleotide sequences
05/25/1999US5906817 Biocompatible implant for the expression and in vivo secretion of a therapeutic substance
05/25/1999US5906812 Useful for treating intrisic and extrinsic aging such as wrinkles, fine lines, actinic blemishes, dyschromias, dermatitis or scars in human skin; cosmetics
05/25/1999US5906600 Body showing antibacterial effect for application as a medical or surgical aid
05/25/1999CA2062299C Cyclopropane derivatives
05/25/1999CA1340554C Derivatives of pyrido-benzothiazine with high anti-microbial activity
05/20/1999WO1999024613A1 Human blood bacterium
05/20/1999WO1999024589A2 Lysozym-analogous proteins and peptide having an anti-microbial activity, production of the same and use thereof
05/20/1999WO1999024579A1 Novel era
05/20/1999WO1999024578A2 Neisserial antigens
05/20/1999WO1999024576A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene
05/20/1999WO1999024559A2 Nuclear targeting by means of streptococcal protein h
05/20/1999WO1999024440A1 Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
05/20/1999WO1999024428A1 Oxazolidinone derivatives and pharmaceutical compositions
05/20/1999WO1999024419A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999WO1999024416A1 Aminothiazole inhibitors of cyclin dependent kinases
05/20/1999WO1999024404A1 Substituted pyridine compounds as anti-inflammatory agents
05/20/1999WO1999024399A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999WO1999024159A1 Encapsulate of active material in alginate matrix
05/20/1999WO1999024068A1 Immortal avian cell line to grow avian and animal viruses to produce vaccines
05/20/1999WO1999024067A1 Micobacterium vaccae preparation comprising cold-shock proteins and its use in therapy
05/20/1999WO1999024065A1 COMPOUNDS INHIBITING CD4-gp120 INTERACTION AND USES THEREOF
05/20/1999WO1999024054A1 Host derived proteins binding hcv: medical, diagnostic and purification use
05/20/1999WO1999024052A2 Use of protein h as cytostatic agent
05/20/1999WO1999016753A3 Tricyclic 3-oxo-propanenitrile compounds
05/20/1999WO1999015553A3 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use
05/20/1999WO1999011666B1 N-terminal modifications of rantes and methods of use
05/20/1999WO1999010475A3 Attenuated strains of mycobacteria
05/20/1999WO1999007734A3 Hepatitis c inhibitor peptide analogues
05/20/1999WO1999007733A3 Hepatitis c inhibitor peptides
05/20/1999CA2671261A1 Neisserial antigens
05/20/1999CA2309690A1 Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
05/20/1999CA2309640A1 Nuclear targeting by means of bacterial proteins
05/20/1999CA2309559A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene
05/20/1999CA2308779A1 Human blood bacterium
05/20/1999CA2308618A1 Lysozyme-analogous proteins and peptides with an anti-microbial effect, their production and use
05/20/1999CA2308606A1 Neisserial antigens
05/20/1999CA2308361A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999CA2308359A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999CA2305715A1 Host derived proteins binding hcv: medical, diagnostic and purification use
05/20/1999CA2303959A1 Oxazolidinone derivatives and pharmaceutical compositions
05/19/1999EP0916729A2 Novel reductase
05/19/1999EP0916727A2 Novel LysS
05/19/1999EP0916726A1 Attaching substances to micro-organisms
05/19/1999EP0916680A2 Lantibiotic related to Actagardine, process of preparation and use thereof
05/19/1999EP0916678A2 Method of clotting blood
05/19/1999EP0916651A1 Phenylalkylcarboxylic acid derivatives
05/19/1999EP0916344A2 Nef action inhibitor
05/19/1999EP0916343A1 use of alkzl phosphoric acid compounds for the treatment of psoriatic diseases
05/19/1999EP0915978A2 Dna immunization against chlamydia infection
05/19/1999EP0915969A1 Method for preventing hiv-1 infection of cd4+ cells
1 ... 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 ... 1798